Daejeon, South Korea

Yeung Chul Kim



 

Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yeung Chul Kim: Innovator in Cancer Therapeutics

Introduction

Yeung Chul Kim, an accomplished inventor based in Daejeon, South Korea, has made significant contributions to the field of cancer therapeutics. With a total of three patents to his name, Kim's innovative work focuses on the development of antibodies for the treatment and diagnosis of cancer, showcasing his dedication to advancing medical technology.

Latest Patents

Kim's latest patent concerns an antibody against human DLK1, which includes a wide array of applications such as antibody-drug conjugates (ADCs) and pharmaceutical compositions for cancer treatment. This patent enhances the potential for targeted cancer therapies by integrating advanced methodologies for antibody production and application. Additionally, he has developed an antibody to programmed death-ligand 1 (PD-L1), aimed at preventing and treating cancer and infectious diseases. This patent highlights the innovative strategies employed in the fight against complex diseases, validating Kim's reputation as a leading figure in biopharmaceutical innovation.

Career Highlights

Over the course of his career, Yeung Chul Kim has worked with prominent organizations such as Y-Biologics Inc. and Medpacto Inc. These experiences have not only enriched his professional development but also facilitated the practical application of his research findings into viable therapeutic solutions. His dedication to research and product development continues to influence the landscape of cancer treatment methods.

Collaborations

Kim has collaborated with esteemed colleagues, including Jung Chae Lim and Jisu Lee. Together, they have contributed to a collaborative work environment that fosters the exchange of innovative ideas and techniques. Such teamwork is essential in the complex realm of medical research, where diverse expertise can lead to breakthroughs.

Conclusion

In conclusion, Yeung Chul Kim stands out as a prominent inventor whose patents reflect a deep commitment to combating cancer through innovative antibody therapies. His work not only has the potential to transform treatment protocols but also inspires future generations of inventors and researchers in the biomedical field. With his ongoing efforts, the fight against cancer is poised to advance significantly, underscoring the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…